OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM

EIN: 311340154 501(c)(3) Diseases & Disorders

GALENA, OH

Total Revenue
$99,377
Total Expenses
$131,258
Total Assets
$315,778
Net Assets
$218,428
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1992
Legal Domicile
OH
Principal Officer
MATT KALAYCIO
Phone
2164449100
Tax Period
2023-01-01 to 2023-12-31

OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM, founded in 1992, is a micro nonprofit in the Diseases & Disorders sector that reported $99K in total revenue in fiscal year 2023. Revenue decreased 5% compared to the prior year. Expenses of $131K exceeded revenue, resulting in a 32% operating deficit.

Mission

TO ENSURE ALL OHIO RESIDENTS HAVE ACCESS TO QUALITY CARE FOR HEMATOLOGIC MALIGNANCIES.

Program Service Accomplishments

Program 1
Expenses: $123,413

IDENTIFYING PATIENTS FOR TRANSPLANT BASED ON PATIENT SELECTION CRITERIA AND CLINICAL SUMMARIES. PROVIDING ACCESS INFORMATION AND MAINTAINING A STATE WIDE WAITING LIST.

Program 2

PROFESSIONAL/PUBLIC EDUCATION-PROVIDING INFORMATION TO PUBLIC AND INSURERS ABOUT CONSORTIUM, INDICATIONS FOR HSCT, AND STANDARDS FOR CARE.

Program 3

QUALITY ASSURANCE/PROGRAM REVIEW - DEVELOPING STANDARDS FOR REVIEWING PATIENT SUMMARIES AND HSCT PROGRAMS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $89,265
Program Service Revenue $0
Investment Income $62
Other Revenue $10,050
TOTAL REVENUE $99,377

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $123,413
Other Expenses $131,258
TOTAL EXPENSES $131,258

Year-over-Year Comparison

2023 2022 Change
Revenue $99,377 $105,149 -0.1%
Expenses $131,258 $82,574 +0.6%
Net Income $-31,881 $22,575 -2.4%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
5
Independent Members
5
Employees
N/A
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
0
$0
Total Directors
5
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JEFFREY AULETTA BOARD MEMBER N/A
Director
$0 $0 $0
MATT KALAYCIO BOARD CHAIRM N/A
Director
$0 $0 $0
BERNI MCQUIGG BOARD TREASU N/A
Director
$0 $0 $0
JAMES ESSELL MD BOARD MEMBER N/A
Director
$0 $0 $0
STEVEN KUERBITZ MD BOARD MEMBER N/A
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 No data No data No data No data
2024 No data No data No data No data
2023 $99,377 $131,258 $315,778 $-31,881
2022 $105,149 $82,574 $330,785 $22,575
2021 $79,026 $72,060 $268,795 $6,966
2020 $76,902 $82,852 $510,484 $-5,950
2019 $106,798 $102,793 $494,686 $4,005
2018 $102,574 $83,763 $424,945 $18,811
Explore More Nonprofits
→Top 100 Nonprofits in Ohio →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM with other nonprofits in Ohio and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.